States that resisted expanding their Medicaid programs still saw an increase in new enrollees through the end of March.
States that resisted expanding their Medicaid programs still saw an increase in new enrollees through the end of March. According to a market analysis from Avalare Health, a minimum of 550,300 new people signed up for Medicaid benefits in 17 out of the 26 states that refused to accept federal health reform funding. Had those states chosen to expand their Medicaid programs under the Affordable Care Act (ACA), many would have benefited from the additional funding.
“I don’t think a lot of these states anticipated the kind of enrollment they would be getting,” said Avalere CEO Dan Mendelson. “The states are going to have to figure out a way to pay for the increase.”
Georgia enrolled 99,000 new Medicaid beneficiaries, while North Carolina saw 58,000 new consumers sign up. Virginia saw a 3.6% increase, with 37,000 new enrollees. The drastic increases in enrollment show that these particular states are experiencing the most extreme outcomes of the “woodwork effect.” While the federal government pays the full cost for enrollees in ACA-expanded Medicaid programs through 2016, average woodwork enrollees are reimbursed under the traditional Medicare payment model, which covers only 57% of costs. States must pick up the rest of the tab.
“Though new eligibles are 100% federally funded through 2016, states only receive their standard matching rate for these previously eligible beneficiaries,” said Caroline Pearson, vice president at Avalere Health. “As a result, many of these nonexpansion states that politically oppose the ACA are now facing unexpected financial and operational pressure due to woodwork enrollment.”
Around the Web
Medicaid Rolls Grow in States Resisting Health Law
In Red States, Obamacare Outreach Boosts Medicaid Enrollment [Forbes]
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen